COMMUNIQUÉS West-GlobeNewswire
-
VBI Vaccines to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
28/08/2018 - 14:00 -
Aeglea BioTherapeutics to Present at 2018 Wells Fargo Healthcare Conference
28/08/2018 - 14:00 -
Spero Therapeutics to Present New Data for SPR994 and SPR206 at ESCMID/ASM 2018 Conference
28/08/2018 - 14:00 -
Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 20th Annual Global Investment Conference on Wednesday, September 5, 2018
28/08/2018 - 13:50 -
Theratechnologies Files Marketing Authorization Application for Trogarzo™ in Europe
28/08/2018 - 13:38 -
Theratechnologies soumet la demande d’autorisation de mise en marché de Trogarzo(MC) en Europe
28/08/2018 - 13:38 -
Strongbridge Biopharma plc Announces Presentations at Two Upcoming Investor Conferences
28/08/2018 - 13:31 -
Strongbridge Biopharma plc Announces New Employment Inducement Awards
28/08/2018 - 13:30 -
Biogen and Eisai Report Data from Long-Term Extension Phase 1b Study of Investigational Alzheimer’s Disease Treatment Aducanumab
28/08/2018 - 13:30 -
Assembly Biosciences to Present at Upcoming Investor Conferences
28/08/2018 - 13:05 -
Sonoma Pharmaceuticals Announces Results from Study of Sonoma’s Performance-Stabilized HOCl™ (Hypochlorous Acid) in Management of Acne Vulgaris
28/08/2018 - 13:05 -
Protech Home Medical Releases Third Quarter Financial Results
28/08/2018 - 13:04 -
Kymriah® (tisagenlecleucel, formerly CTL019) receives European Commission Approval
28/08/2018 - 13:00 -
AxoGen, Inc. to Present at the Morgan Stanley Global Healthcare Conference
28/08/2018 - 13:00 -
Aleafia Posts Record Revenue in Q2 with 160,000 sq ft Niagara Greenhouse to be Fully Operational in Late 2018
28/08/2018 - 13:00 -
XOMA to Present at the H. C. Wainwright 20th Annual Global Investment Conference
28/08/2018 - 13:00 -
First Patient Enrolled in Anavex Life Sciences Phase 2b/3 Clinical Trial of ANAVEX®2-73 for the Treatment of Early Alzheimer’s Disease
28/08/2018 - 13:00 -
PetVivo Holdings, Inc. Adds Daniel P. Collins, Ph.D. as Chief Science Officer
28/08/2018 - 13:00 -
Axsome Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
28/08/2018 - 13:00
Pages